Takeda and Frazier Healthcare Partners Announce Collaboration to Launch HilleVax, Inc. to Develop Clinical Stage Norovirus Vaccine Candidate

July 29, 2021
12:36 pm

Takeda and Frazier Healthcare Partners Announce Collaboration to Launch HilleVax, Inc. to Develop Clinical Stage Norovirus Vaccine Candidate

CAMBRIDGE, Mass. & MENLO PARK, Calif.–(BUSINESS WIRE)–Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) (Takeda) and Frazier Healthcare Partners (Frazier) today announced a collaboration to launch HilleVax, Inc. (HilleVax), a biopharmaceutical…

Click here to view the original article.

Business Wire, Global

Share this article

Man paid to tattoo meme coin on his forehead — then the typo became a real coin

June 14, 2026

FIFA World Cup 2026 kicks off with Germany vs Curaçao as crypto partnerships reshape fan engagement

June 14, 2026

Kraken Is Fueling FIFA World Cup Fever With Crypto

June 14, 2026

CCC Intelligent Solutions (CCC) Stock Valuation After Prolonged Share Price Weakness

June 14, 2026

The $20B Bank vs Crypto Exchange Battle

June 14, 2026

Scotts Miracle-Gro (SMG) Stock Valuation Snapshot After Recent Price Momentum

June 14, 2026

Tether, NVIDIA, Amazon Back $1.4B Humanoid Robot’s Crypto Wallet Deal

June 14, 2026

Bank Of Nova Scotia (TSX:BNS) Stock Valuation After Recent Share Price Strength

June 14, 2026